COSENTYX (secukinumab) — NDC 0078-0639 by Novartis Pharmaceuticals Corporation
COSENTYX (secukinumab) — NDC 0078-0639 by Novartis Pharmaceuticals Corporation is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: COSENTYX; Generic name: secukinumab; Product NDC: 0078-0639.
| Brand name | COSENTYX |
|---|---|
| Generic name | secukinumab |
| Product NDC | 0078-0639 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Dosage form | INJECTION |
| Route | SUBCUTANEOUS |
| Active ingredients | SECUKINUMAB 150 mg/mL |
| Pharmacologic class | Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA] |
| Marketing category | BLA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →